I
Insmed Inc (INSM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$122.88
+1.72 (+1.42%)
Market Cap: $26.58B
Last updated: Nov 17, 2026 at 11:06 AM ET
Insmed Inc (INSM) Valuation Multiples
Insmed (INSM) trades at 17.7x sales and 37.0x book value. Its P/S of 17.7x is above its 5-year median of 16.3x. Its forward P/E is 107.5x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 107.5x |
| Price to sales | 17.7x |
| Price to book | 37.0x |
| PEG | N/A |
| FCF yield | -2.3% |
Historical Medians
Against its 10-year medians, its P/B is 242.6% above 10.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 17.7x | 16.3x | N/A |
| P/B | 37.0x | N/A | 10.8x |
Valuation History
Over the 8 of the 10 year ends shown that have a P/S, its P/S ranged from 10.0x in 2022 to 102.8x in 2018.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $174.04 | 58.2x | 50.3x |
| 2024 | $69.04 | 31.2x | 43.3x |
| 2023 | $30.99 | 14.3x | N/A |
| 2022 | $19.98 | 10.0x | 30.1x |
| 2021 | $27.24 | 16.2x | 7.9x |
| 2020 | $33.29 | 19.8x | 12.3x |
| 2019 | $23.88 | 15.0x | 8.2x |
| 2018 | $13.12 | 102.8x | 4.9x |
| 2017 | $31.18 | N/A | 6.6x |
| 2016 | $13.23 | N/A | 5.3x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INSM
What is INSM's forward P/E ratio?
Insmed has a forward P/E ratio of 107.5x.
Is INSM stock overvalued?
GNG's valuation label for INSM is Fairly valued.
What is INSM's price to sales ratio?
Insmed has a price to sales ratio of 17.7x.
INSM pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts